Last update 01 Nov 2024

Ipratropium bromide/Xylometazoline Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
ZyComb
Target
ADRA1 x ADRA2 x mAChRs
Mechanism
ADRA1 agonists(Adrenergic receptor alpha-1 agonists), ADRA2 agonists(Adrenergic receptors alpha-2 agonists), mAChRs antagonists(Muscarinic acetylcholine receptor antagonists)
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
Common Cold
Inactive Indication-
Originator Organization
Takeda Pharmaceutical Co., Ltd.Takeda Pharmaceutical Co., Ltd.
Active Organization
Takeda Pharmaceutical Co., Ltd.Takeda Pharmaceutical Co., Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC16H25ClN2
InChIKeyYGWFCQYETHJKNX-UHFFFAOYSA-N
CAS Registry1218-35-5

Related

1
Clinical Trials associated with Ipratropium bromide/Xylometazoline Hydrochloride
NCT00480194 / CompletedNot Applicable
A Non-interventional, Non-controlled, Post-marketing Study to Obtain Knowledge of the Safety of ZyComb® (Xylometazoline Hydrochloride 0.5 mg/mL and Ipratropium Bromide 0.6 mg/mL) for Symptoms of Common Cold in a Real-life OTC Setting
100 Clinical Results associated with Ipratropium bromide/Xylometazoline Hydrochloride
Login to view more data
100 Translational Medicine associated with Ipratropium bromide/Xylometazoline Hydrochloride
Login to view more data
100 Patents (Medical) associated with Ipratropium bromide/Xylometazoline Hydrochloride
Login to view more data
100 Deals associated with Ipratropium bromide/Xylometazoline Hydrochloride
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
R01AA07S01GA03R01AB06
-

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Common Cold-
Takeda Pharmaceutical Co., Ltd.Takeda Pharmaceutical Co., Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free